Filing Details
- Accession Number:
- 0001209191-15-066319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-17 17:03:51
- Reporting Period:
- 2015-08-14
- Filing Date:
- 2015-08-17
- Accepted Time:
- 2015-08-17 17:03:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1572000 | Charles David Lubner | 480 Arsenal St. Suite 110 Watertown MA 02472 | Svp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-14 | 9,500 | $7.94 | 78,770 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-14 | 9,500 | $42.92 | 69,270 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-08-14 | 9,500 | $0.00 | 9,500 | $7.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
123,799 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $41.93 to $43.29 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option vests as to 25% of the shares on May 15, 2014 and further vests as to 6.25% of the shares at the end of each of successive three-month period thereafter until May 15, 2017.